Suchergebnisse - "Knapper, Steven"

PubPharm (9)

1

Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML

enthalten in: Blood advances | 2024

von Jimenez-Chillon, C. | Othman, J. | Taussig, D. | +29

2

Tamoxifen for the treatment of myeloproliferative neoplasms : A Phase II clinical trial and exploratory analysis

enthalten in: Nature communications | 2023

von Fang, Z. | Corbizi Fattori, G. | McKerrell, T. | +33

3

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy : results from a multicenter, randomized, phase 2/3 study

enthalten in: Leukemia | 2021

von Montesinos, P. | Roboz, G. | Bulabois, C. | +22

4

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML

enthalten in: Blood | 2017

von Knapper, S. | Russell, N. | Gilkes, A. | +10

CommentIn: Blood. 2017 Mar 2;129(9):1061-1062. - PMID 28254820

5

Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis : results of the UK ROBUST Trial

enthalten in: British journal of haematology | 2015

von Mead, A. | Milojkovic, D. | Knapper, S. | +9

6

Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

enthalten in: Leukemia research | 2014

von Andersen, C. | Bjørn, M. | McMullin, M. | +22

7

Elacytarabine in relapsed/refractory acute myeloid leukaemia : an evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile

enthalten in: Leukemia research | 2014

von Knapper, S. | Chevassut, T. | Duarte, R. | +8

8

A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia

enthalten in: British journal of haematology | 2013

von Andersen, C. | McMullin, M. | Ejerblad, E. | +17

9

A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy

enthalten in: Blood | 2006

von Knapper, S. | Burnett, A. | Littlewood, T. | +6

1
[1]